Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Dr Soliman Abdul Kader Fakeeh Hospital Co Altman Z-Score?
Dr Soliman Abdul Kader Fakeeh Hospital CoSAU:4017 -1.03%14 Altman Z-Score is 3.22 as of Jul. 16, 2026, which is 25% below its 10-year median of 4.31. GuruFocus rates SAU:4017 with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks better than 62.22% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 3.28 is strong.
Dr Soliman Abdul Kader Fakeeh Hospital Co has a Altman Z-Score of 3.22, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Soliman Abdul Kader Fakeeh Hospital Co Altman Z-Score Chart
Dr Soliman Abdul Kader Fakeeh Hospital Co Annual Data
Trend
Dec23
Dec24
Dec25
Altman Z-Score
0.00
5.86
3.27
Dr Soliman Abdul Kader Fakeeh Hospital Co Quarterly Data
SAU:4017 vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Soliman Abdul Kader Fakeeh Hospital Co Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score falls into.
Dr Soliman Abdul Kader Fakeeh Hospital Co Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a Altman Z-Score of 3.22 as of Jul. 16, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. This is 25% below median its historical median of 4.31. Over the past decade, Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score has ranged from 3.17 to 5.86. According to the industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #249 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 37.8%.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score too high?
Dr Soliman Abdul Kader Fakeeh Hospital Co's current Altman Z-Score of 3.22 is 25% below median its 10-year median of 4.31. Over the past 10 years, this metric has ranged from a low of 3.17 to a high of 5.86. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 3.22 is 31.4% above this industry median. Based on the distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #249 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dr Soliman Abdul Kader Fakeeh Hospital Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Dr Soliman Abdul Kader Fakeeh Hospital Co's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Soliman Abdul Kader Fakeeh Hospital Co ranks #249 out of 659 companies for Altman Z-Score. This puts Dr Soliman Abdul Kader Fakeeh Hospital Co in the upper half of its industry. The industry median Altman Z-Score is 2.45. Dr Soliman Abdul Kader Fakeeh Hospital Co's value of 3.22 is 31.4% above this benchmark. Historically, Dr Soliman Abdul Kader Fakeeh Hospital Co's own Altman Z-Score has ranged from 3.17 to 5.86 over the past decade. While the company's 10-year median is 4.31 vs. the industry median of 2.45, Dr Soliman Abdul Kader Fakeeh Hospital Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Soliman Abdul Kader Fakeeh Hospital Co's current Altman Z-Score of 3.22 is 31.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Dr Soliman Abdul Kader Fakeeh Hospital Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Soliman Abdul Kader Fakeeh Hospital Co's current Altman Z-Score is 3.22, which is 25% below median its own 10-year median of 4.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Soliman Abdul Kader Fakeeh Hospital Co stock overvalued right now?
Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017) has a current Altman Z-Score of 3.22. The current Altman Z-Score is 3.22, which is 25% below median its 10-year median of 4.31 and 31.4% above the Healthcare Providers & Services industry median of 2.45. Dr Soliman Abdul Kader Fakeeh Hospital Co's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Dr Soliman Abdul Kader Fakeeh Hospital Co (SAU:4017), the current Altman Z-Score is 3.22 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Soliman Abdul Kader Fakeeh Hospital Co Business Description
Dr Soliman Abdul Kader Fakeeh Hospital Co is a company whose principal activities include managing, establishing, and operating hospitals, clinics, medical, educational, and training centers. In addition to the above, the company is also managing and operating medical services, analysis and radiology laboratory, and managing and establishing pharmacies, wholesale and retail of medical equipment, maintenance of IT equipment, and software-related services. The group has three reportable segments, including medical services, which generates maximum revenue, education, trading, retail, and others. Geographically, it principally operates in the Kingdom of Saudi Arabia.
14GF Score
Get the complete analysis for SAU:4017
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4017 has been successfully added to your 
